Institute of Liver and Biliary Sciences, India Clinical Trials
Sponsors / Institute of Liver and Biliary Sciences, India
Institute of Liver and Biliary Sciences, India appears as lead sponsor on 268 trial records in ClinicalTrials.gov. Of these, 22 are recruiting, 0 are active without new recruitment, and 119 have completed. The registry records 3 terminated or withdrawn trials for Institute of Liver and Biliary Sciences, India. The most common reasons cited for termination include efficacy or futility findings. Planned participant enrollment across these trials sums to 37,908. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
268
Total Trials
22
Recruiting
0
Other Active
119
Completed
3
Terminated / Withdrawn
37,908
Total Enrollment
Termination reasons: Other67% · Efficacy33%
Recent Terminations
- Acute on Chronic Liver Failure
- HCV Related Cirrhosis"In view of recent approval of NS5A inhibitors for treatment of hepatitis C such as Declatasvir and Ledipasvir which have proven better efficacy in the HCV cure"
- Drug Induced Liver Injury"Steroids were given for 2 patients who had biopsy proven Drug induced Liver Injury and both have them developed sepsis."
Active Trials (0 total)
- NCT06768216
- NCT06831643
- NCT07299110
- NCT07263061
- NCT07268196
- NCT06909188
- Cirrhosis NANCT01212250
- NCT07108075
- NCT07085806
- NCT06831565
- NCT06736093
- NCT06743464
- NCT06676813
- NCT06026267
- NCT06153082
- NCT06496191
- NCT06475911
- NCT06396546
- NCT06447051
- NCT06361732